Christopher Andrew Barker, Ryan Michael Lanning, Shlomo A. Koyfman, Jay Justin Liao, Upendra Parvathaneni, Bhisham Chera, Thomas James Galloway, Kaveh Zakeri, Yao Yu, Linda Chen, Achraf Shamseddine, Daphna Y. Gelblum, Alan Loh Ho, Nancy Y. Lee, Zhigang Zhang, Lara Dunn. "A phase II, multicenter, single-arm clinical trial of response-adapted definitive radiotherapy and cemiplimab-rwlc immunotherapy for locally advanced, unresectable cutaneous squamous cell carcinoma: RAMPART.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.9506